Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Cited In for PubMed (Select 20876541)

1.

Pancreatic cancer-improved care achievable.

Buanes TA.

World J Gastroenterol. 2014 Aug 14;20(30):10405-18. doi: 10.3748/wjg.v20.i30.10405.

2.

Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma.

Zhang LJ, Wang KB, Liu LS, Chen LZ, Peng BG, Liang LJ, Li Z, Xue L, Li W, Xia JT.

BMC Cancer. 2014 Aug 7;14:571. doi: 10.1186/1471-2407-14-571.

3.
4.

High-quality endoscopic ultrasound-guided fine needle aspiration tissue acquisition.

Holt BA, Varadarajulu S, Hébert-Magee S.

Adv Ther. 2014 Jul;31(7):696-707. doi: 10.1007/s12325-014-0129-5. Epub 2014 Jun 24.

5.

Intensity of follow-up after pancreatic cancer resection.

Castellanos JA, Merchant NB.

Ann Surg Oncol. 2014 Mar;21(3):747-51. doi: 10.1245/s10434-013-3289-7. Epub 2013 Oct 4. Review.

6.

The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma.

Wild AT, Ye X, Ellsworth SG, Smith JA, Narang AK, Garg T, Campian J, Laheru DA, Zheng L, Wolfgang CL, Tran PT, Grossman SA, Herman JM.

Am J Clin Oncol. 2013 May 2. [Epub ahead of print]

7.

Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma.

Foo WC, Rashid A, Wang H, Katz MH, Lee JE, Pisters PW, Wolff RA, Abbruzzese JL, Fleming JB, Wang H.

Hum Pathol. 2013 Jun;44(6):1024-30. doi: 10.1016/j.humpath.2012.09.001. Epub 2012 Dec 20.

8.
9.
10.

Pancreatic cancer: current standards, research updates and future directions.

Hsueh CT.

J Gastrointest Oncol. 2011 Sep;2(3):123-5. doi: 10.3978/j.issn.2078-6891.2011.037. No abstract available.

11.

Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI).

Butt Z, Parikh ND, Beaumont JL, Rosenbloom SK, Syrjala KL, Abernethy AP, Benson AB 3rd, Cella D.

Cancer. 2012 Dec 1;118(23):5997-6004. doi: 10.1002/cncr.27588. Epub 2012 May 17.

12.

Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy.

Fischer R, Breidert M, Keck T, Makowiec F, Lohrmann C, Harder J.

Saudi J Gastroenterol. 2012 Mar-Apr;18(2):118-21. doi: 10.4103/1319-3767.93815.

13.

Increased organ sparing using shape-based treatment plan optimization for intensity modulated radiation therapy of pancreatic adenocarcinoma.

Petit SF, Wu B, Kazhdan M, Dekker A, Simari P, Kumar R, Taylor R, Herman JM, McNutt T.

Radiother Oncol. 2012 Jan;102(1):38-44. doi: 10.1016/j.radonc.2011.05.025. Epub 2011 Jun 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk